Skip to main content

Fluad Quadrivalent FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 27, 2021.

FDA Approved: Yes (First approved February 21, 2020)
Brand name: Fluad Quadrivalent
Generic name: influenza vaccine, adjuvanted
Dosage form: Injection
Company: Seqirus
Treatment for: Influenza Prophylaxis

Fluad Quadrivalent (influenza vaccine, adjuvanted) is an inactivated influenza virus vaccine approved for the prevention of seasonal influenza in adults 65 years and older.

Development timeline for Fluad Quadrivalent

Feb 24, 2020Approval FDA Approves Fluad Quadrivalent (influenza vaccine, adjuvanted) for Influenza Prophylaxis in Adults 65 Years and Older

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.